Biocartis
Biocartis, SkylineDx Partner to Develop Melanoma Nodal Metastasis Risk Test
The Belgian molecular diagnostics firm also reported a 70 percent year-over-year increase in commercial cartridge volumes in the first quarter.
Biocartis, AstraZeneca Expand Lung Cancer Biomarker Study With Master Collaboration Agreement
The partners will extend the lung cancer biomarker study to countries in and outside Europe, and see if liquid biopsy could offer benefits to tissue-based testing.
Comparison of KRAS Liquid Biopsy Kits Confirms Differences at Low Mutant Allele Fraction
Biocartis' Idylla called some colorectal cancer samples negative that Sysmex Inostics's OncoBEAM called positive, but the clinical implications may be complex.
Biocartis, Kite Sign Development Agreement for Immunotherapy Assays
The agreement is part of Biocartis' long term plans to expand its presence in the oncology field by building a menu of tests for immunotherapies.
Biocartis, AstraZeneca Partner on European Lung Cancer Biomarker Study
The firms will begin a prospective lung cancer study using Biocartis' Idylla EGFR mutation test in European countries, including Belgium, France, Germany, and Italy.